SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 3 — Focused Visit (Follow-up) — Bob Marley — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientBob Marley
Date of birth1945-02-06
IdentifiersMRN HR-ML027-SYN-TD; SSN (made up) 000-27-4065
Document date1977-07-15
AuthorDesmond Clarke, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Review two weeks after excision of the toenail unit and sentinel node biopsy. [S]

History of Present Illness

Mr. Marley returns two weeks after digit-sparing en bloc excision of the nail unit of his right great toe, with a full-thickness skin graft from the inner upper arm and a right inguinal sentinel node biopsy, as a day case. The tie-over dressing came off at one week and the graft had taken. He took acetaminophen for nine days and needs nothing now. He walks in the stiff-soled postoperative shoe and has kept the foot raised when resting. The groin wound is comfortable, with no swelling. The final pathology is back. He has had no thoughts of self-harm. [S]

ElementDetail
OperationDigit-sparing excision of the nail unit, full-thickness skin graft, and right inguinal sentinel node biopsy, as a day case
PathologyNo residual invasive melanoma; margins clear (closest 6 mm); both sentinel nodes negative
Final stagepT1b pN0(sn) M0, pathologic stage IA
RecoveryGraft taken; walking in a postoperative shoe; no pain medicine
PlansWants to run and play football again, and to tour later in the year

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo fever
MusculoskeletalPositiveToe stiff and tender when walking far; no other pain
IntegumentaryNegativeGraft and donor site healing; no discharge
Hematologic and lymphaticNegativeNo groin swelling or leg swelling
PsychiatricNegativeRelieved by the result; PHQ-2 score 0

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Acetaminophen 500 mg oral tablet, two tablets by mouth every 6 hours as needed for pain after surgery, no more than 3 g a dayTwo tablets every 6 hours as neededOral route1977-07-01 to 1977-07-10completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1977-07-15Body height170cmS
1977-07-15Body weight65.4kgS
1977-07-15Body mass index (BMI) [Ratio]22.6kg/m2S
1977-07-15Systolic blood pressure116mm[Hg]S
1977-07-15Diastolic blood pressure72mm[Hg]S
1977-07-15Heart rate66/minS
1977-07-15Respiratory rate14/minS
1977-07-15Body temperature36.7CelS
1977-07-15Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1977-07-15Pain severity - 0-10 verbal numeric rating [Score] - Reported2{score}S
1977-07-15Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S

Physical Exam

Vital signs recorded on 1977-07-15; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 116/72, pulse 66; weight 65.4 kg
Right great toeGraft about 95 percent taken, pink and adherent, with a small area of superficial crusting at the tip; no infection; toe movement nearly full
Right groinIncision healed; no seroma or swelling
Right armDonor site on the inner upper arm healing in a straight line
ExtremitiesNo leg swelling

Problems

ProblemClinical statusVerificationCodeProvenance
A brown-black band in the right great toenail, about 5 mm wide (about a third of the nail), with irregular dark lines, first noticed about two months ago after a knock at football and not growing out with the nail; the pigment extends onto the skin of the proximal nail fold (Hutchinson sign). Suspected subungual melanoma; dermoscopy and a full-thickness nail matrix biopsy booked this weekresolvedconfirmed L60.8S — Synthetic presenting problem linked to his documented toe lesion; superseded by the diagnosis at the surgical oncology consultation.
Acral lentiginous melanoma of the nail unit (subungual) of the right great toe, on full-thickness nail matrix biopsy: Breslow thickness 0.8 mm, not ulcerated, mitotic rate 1 per mm2, no lymphovascular or perineural invasion; clinical stage IB (cT1b N0 M0); synthetic modern detail linked to his documented acral lentiginous melanomaactiveconfirmed C43.71S — Synthetic thickness and stage; the site, the subtype, and the year are documented (D).

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
LaboratoryFinal pathology of the excision and sentinel nodesAfter definitive surgeryCompleted todayNo residual invasive melanoma; margins clear, closest 6 mm; 0 of 2 sentinel nodes involved
LaboratoryAJCC 8th edition pathologic stageAfter definitive surgeryCompleted todaypT1b pN0(sn) M0, stage IA
Medication safetyAdjuvant systemic therapyConsidered from stage IIBNot indicatedStage IA
ExaminationGraft, donor site, and groin woundEach visit until healedCompleted todayGraft 95 percent taken; groin and arm healing; no infection or seroma
ExaminationExamination of the lymph node basins (right popliteal and inguinal) and the scarAt diagnosis, then at each surveillance visitCompleted todayNo nodes; groin scar healed
ImagingImaging (CT, PET, or ultrasound) and LDHNot routine for stage I to II without symptomsNot indicatedStage IA without symptoms
Self-managementSkin self-examinationMonthly, taught after diagnosis and reviewed each visitCompleted todayTaught today with a mirror and a handout: the palms, soles, between the toes and all nails, the sites people with darker skin most need to check, and the graft and both groins; he will photograph the graft each month
Self-managementFootwear and return to activityAfter nail unit surgeryCompleted todayStiff-soled shoe until the graft has healed; running after it heals; football after the six-week graft check
SurveyPain scoreEach visit after surgeryCompleted todayWorst pain 2 of 10, only after walking far
SurveyDepression screen (PHQ-2)At each phase of careCompleted todayPHQ-2 score 0

Goal progress:

Guideline basis: NCCN Clinical Practice Guidelines in Oncology: Melanoma: Cutaneous, Version 3.2026 (2026); Swetter SM, et al. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol 2019;80(1):208-250 (2019); Gershenwald JE, et al. Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 2017;67(6):472-492 (2017); Chouquet L, et al. Reconstruction After Wide Excision of the Nail Apparatus in the Treatment of Melanoma: A Systematic Literature Review. J Clin Med 2025;14(17):5932 (2025); Depression and Suicide Risk in Adults: Screening (2023)

Follow-up: Graft check by the surgical team at six weeks. Preventive visit in about two months. Melanoma review about three months after surgery. Next scheduled visit 1977-09-21: periodic adult preventive visit. [S]